PreveCeutical Medical (PRVCF) News Today $0.02 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period PreveCeutical Medical Inc PRVCFMarch 15, 2024 | morningstar.comPreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD ApplicationSeptember 18, 2023 | finance.yahoo.comPreveCeutical Showcases Dynamic Evolution in AI StrategySeptember 12, 2023 | finance.yahoo.comPreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses ThereofJune 28, 2023 | finance.yahoo.comPreveCeutical Medical - Sol-Gel and Uses thereof Patent UpdateMay 30, 2023 | finance.yahoo.comPreveCeutical Medical Launches Clinical Artificial Intelligence DivisionApril 24, 2023 | finance.yahoo.comPreveCeutical Medical Announces Live Interactive Q&A Video ConferenceApril 20, 2023 | finance.yahoo.comPreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe PainApril 4, 2023 | finance.yahoo.comPreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure CommitteeMarch 20, 2023 | finance.yahoo.comPRVCF PreveCeutical Medical Inc.February 23, 2023 | seekingalpha.comAppointment of C. Evan Ballantyne to PreveCeutical's Board of DirectorsFebruary 21, 2023 | finance.yahoo.comPreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical DevelopmentFebruary 7, 2023 | finance.yahoo.comPreveCeutical, Endosane team up for sol-gel tech use in cannabis therapyJanuary 14, 2023 | msn.comPreveCeutical Enters into License Option Agreement with Endosane PharmaceuticalsJanuary 12, 2023 | finance.yahoo.comPreveCeutical Signs Intercompany Sol-Gel License AgreementJanuary 9, 2023 | finance.yahoo.comThe Power Play by The Market Herald Releases New Interviews with Eloro Resources, Prospera, Datametrex, Gamelancer Media, Infinity Stone Ventures and PreveCeutical Medical Discussing Their Latest NewsNovember 23, 2022 | finance.yahoo.comPreveCeutical Files Application for D-amino Acid PeptidesNovember 21, 2022 | finance.yahoo.comPreveCeutical Medical Inc.: PreveCeutical Announces Conversion of DebtNovember 12, 2022 | finanznachrichten.dePreveCeutical Announces Conversion of DebtNovember 12, 2022 | finance.yahoo.comAppointment of Kathleen Rotika to PreveCeutical's Board of DirectorsOctober 20, 2022 | finance.yahoo.comPreveCeutical Announces Resignation of Board of Director MemberSeptember 17, 2022 | finance.yahoo.comAppointment of Sachin Nanavati to PreveCeutical's Board of DirectorsSeptember 6, 2022 | finance.yahoo.comPreveCeutical Announces Change in Directors and Investor Awareness ServicesMay 27, 2022 | finance.yahoo.comArticle Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of PharmacologyMay 9, 2022 | finance.yahoo.comPreveCeutical Files International Patent Application for Sol-Gel Cannabinoid Formulation for Antiviral UseNovember 29, 2021 | finance.yahoo.comPreveCeutical Files Provisional Patent Application for D-Amino Acid PeptidesNovember 24, 2021 | finance.yahoo.comPreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest's Sol-Gel Technology for Delivery of CannabinoidsNovember 18, 2021 | finance.yahoo.comPreveCeutical Receives AU$315,338 Research & Development Tax Incentive Cash RefundAugust 31, 2021 | finance.yahoo.com Get PreveCeutical Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVCF and its competitors with MarketBeat's FREE daily newsletter. Email Address NASDAQ traded stock with a BIG short position. (Ad)Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth! See how this NASDAQ Bio-tech is offering viable solutions PRVCF Media Mentions By Week PRVCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRVCF News Sentiment▼0.000.44▲Average Medical News Sentiment PRVCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRVCF Articles This Week▼00▲PRVCF Articles Average Week Get PreveCeutical Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Nicox News DIAGNOS News FuelPositive News Blackstone Minerals News Fobi AI News Nextech3D.AI News Else Nutrition News Reliq Health Technologies News BZAM News Bricks Newco News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PRVCF) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PreveCeutical Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PreveCeutical Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
